Defining central themes in breast cancer biology by differential proteomics: conserved regulation of cell spreading and focal adhesion kinase.
暂无分享,去创建一个
Nicholas W Bateman | Brian L Hood | Thomas P Conrads | T. Conrads | B. Hood | M. Flint | N. Bateman | Mai Sun | Mai Sun | Melanie S Flint
[1] In‐San Kim,et al. Identification of Motifs for Cell Adhesion within the Repeated Domains of Transforming Growth Factor-β-induced Gene,βig-h3 * , 2000, The Journal of Biological Chemistry.
[2] B. Konety,et al. Nuclear structural proteins as biomarkers of cancer , 1999, Journal of cellular biochemistry.
[3] Emilio Marengo,et al. The principle of exhaustiveness versus the principle of parsimony: a new approach for the identification of biomarkers from proteomic spot volume datasets based on principal component analysis , 2010, Analytical and bioanalytical chemistry.
[4] S. Bao,et al. The multifaceted role of periostin in tumorigenesis , 2009, Cellular and Molecular Life Sciences.
[5] J. Russo,et al. Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. , 1990, Cancer research.
[6] C. Streuli,et al. Control of Normal Mammary Epithelial Phenotype by Integrins , 1998, Journal of Mammary Gland Biology and Neoplasia.
[7] M. Humphries,et al. Cell adhesion to fibrillin-1: identification of an Arg-Gly-Asp-dependent synergy region and a heparin-binding site that regulates focal adhesion formation , 2007, Journal of Cell Science.
[8] G. Watkins,et al. Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance. , 2006, International journal of oncology.
[9] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[10] M. Hegi,et al. Combined lysophosphatidic acid/platelet-derived growth factor signaling triggers glioma cell migration in a tenascin-C microenvironment. , 2008, Cancer research.
[11] B. Flaxman,et al. Growth of normal human mammary gland epithelium in vitro. , 1972, Cancer research.
[12] Mina J. Bissell,et al. Putting tumours in context , 2001, Nature Reviews Cancer.
[13] Richard D. Smith,et al. Quantitative proteome analysis of breast cancer cell lines using 18O‐labeling and an accurate mass and time tag strategy , 2006, Proteomics.
[14] E. Gelmann,et al. Differentiation state and invasiveness of human breast cancer cell lines , 2004, Breast Cancer Research and Treatment.
[15] T. Orfeo,et al. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. , 1977, Journal of the National Cancer Institute.
[16] F. Giancotti,et al. Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling. , 2000, The Journal of clinical investigation.
[17] Mina J. Bissell,et al. Extracellular matrix control of mammary gland morphogenesis and tumorigenesis: insights from imaging , 2008, Histochemistry and Cell Biology.
[18] K. Das,et al. Coordinate loss of fibroblast growth factor 2 and laminin 5 expression during neoplastic progression of mammary duct epithelium. , 2007, Human pathology.
[19] M. Kern,et al. Angiotensin II, Focal Adhesion Kinase, and PRX1 Enhance Smooth Muscle Expression of Lipoma Preferred Partner and its Newly Identified Binding Partner Palladin to Promote Cell Migration , 2007, Circulation research.
[20] Michael K. Wendt,et al. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-β signaling and metastasis , 2009, Breast Cancer Research.
[21] C. Fenoglio-Preiser,et al. Ultrastructural and Immunocytochemical Features of Ovarian Tumors , 1986 .
[22] David G Camp,et al. Comparison of normal and breast cancer cell lines using proteome, genome, and interactome data. , 2005, Journal of proteome research.
[23] K. Midwood,et al. J. Cell Commun. Signal. (2009) 3:287–310 DOI 10.1007/s12079-009-0075-1 RESEARCH ARTICLE The role of tenascin-C in tissue injury and tumorigenesis , 2009 .
[24] D. Horsfall,et al. Expression of Extracellular Matrix Components Versican, Chondroitin Sulfate, Tenascin, and Hyaluronan, and Their Association with Disease Outcome in Node-Negative Breast Cancer , 2004, Clinical Cancer Research.
[25] R. Cardiff,et al. Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression , 2007, Proceedings of the National Academy of Sciences.
[26] Pierre Legrain,et al. Comprehensive Proteomic Analysis of Breast Cancer Cell Membranes Reveals Unique Proteins with Potential Roles in Clinical Cancer* 210 , 2003, The Journal of Biological Chemistry.
[27] T. Hei,et al. BigH 3 protein expression as a marker for breast cancer , 2008 .
[28] F. Bertucci,et al. Gene expression profiling of breast cell lines identifies potential new basal markers , 2006, Oncogene.
[29] S. Weitzman,et al. The role of laminin-5 and its receptors in mammary epithelial cell branching morphogenesis. , 1997, Journal of cell science.
[30] C. Rüegg,et al. Tenascin‐C inhibits β1 integrin‐dependent T lymphocyte adhesion to fibronectin through the binding of its fnIII 1 – 5 repeats to fibronectin , 1999, European journal of immunology.
[31] Lauren Summers,et al. Adhesion to fibronectin regulates interleukin-1 beta expression in microglial cells , 2009, Molecular and Cellular Neuroscience.
[32] M. Brattain,et al. A novel role of ERK5 in integrin‐mediated cell adhesion and motility in cancer cells via Fak signaling , 2009, Journal of cellular physiology.
[33] A. Kaneda,et al. Identification of silencing of nine genes in human gastric cancers. , 2002, Cancer research.
[34] Junsheng Li,et al. The expression analysis of periostin in human breast cancer. , 2010, The Journal of surgical research.
[35] K. Horiuchi,et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[36] Honghao Li,et al. [Inhibitory effects of transfection of arresten gene on liver metastasis from colorectal cancer in nude mice]. , 2008, Ai zheng = Aizheng = Chinese journal of cancer.
[37] Yi-Wen Chen,et al. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis. , 2010, Journal of proteome research.
[38] W. Gerald,et al. Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. , 2009, The Journal of clinical investigation.
[39] Tatjana Crnogorac-Jurcevic,et al. Palladin Mutation Causes Familial Pancreatic Cancer and Suggests a New Cancer Mechanism , 2006, PLoS medicine.
[40] W. Hancock,et al. An approach to the proteomic analysis of a breast cancer cell line (SKBR‐3) , 2003, Proteomics.
[41] L. Kiesel,et al. On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer , 2007, Breast Cancer Research and Treatment.
[42] S. Kuo,et al. Anthrax toxin: pathologic effects on the cardiovascular system. , 2009, Frontiers in bioscience.
[43] H. Iizuka,et al. Focal adhesion kinase as an immunotherapeutic target , 2009, Cancer Immunology, Immunotherapy.
[44] S. Jeffrey,et al. Transcriptomic signatures in breast cancer. , 2007, Molecular bioSystems.
[45] Goberdhan P Dimri,et al. Mammary epithelial cell transformation: insights from cell culture and mouse models , 2005, Breast Cancer Research.
[46] Burton B. Yang,et al. β1-Integrin-mediated Glioma Cell Adhesion and Free Radical-induced Apoptosis Are Regulated by Binding to a C-terminal Domain of PG-M/Versican* , 2002, The Journal of Biological Chemistry.
[47] Micah Dembo,et al. Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis. , 2007, The international journal of biochemistry & cell biology.
[48] C. Turner,et al. Hic‐5 contributes to epithelial‐mesenchymal transformation through a RhoA/ROCK‐dependent pathway , 2007, Journal of cellular physiology.
[49] M. Dembo,et al. Substrate flexibility regulates growth and apoptosis of normal but not transformed cells. , 2000, American journal of physiology. Cell physiology.
[50] Ma-Kang-Zhuo Bai. Canstatin,a novel matrix-derived inhibitor of angiogenesis and tumor growth , 2003 .
[51] Steven P Gygi,et al. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry , 2007, Nature Methods.
[52] K. Nose,et al. Hic-5-Reduced Cell Spreading on Fibronectin: Competitive Effects between Paxillin and Hic-5 through Interaction with Focal Adhesion Kinase , 2001, Molecular and Cellular Biology.
[53] Y. Hoshikawa,et al. A proteomics study on human breast cancer cell lines by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry. , 2008, Biomedical chromatography : BMC.
[54] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[55] Michael L. Gatza,et al. A pathway-based classification of human breast cancer , 2010, Proceedings of the National Academy of Sciences.
[56] Sami Alom Ruiz,et al. An inhibitory role for FAK in regulating proliferation: a link between limited adhesion and RhoA-ROCK signaling , 2006, The Journal of cell biology.
[57] P. Kenemans,et al. Oncogenic pathways in hereditary and sporadic breast cancer. , 2004, Maturitas.
[58] R. Weichselbaum,et al. Anti-angiogenic cues from vascular basement membrane collagen. , 2000, Cancer research.
[59] S. Souchelnytskyi. Proteomics in Studies of Signal Transduction in Epithelial Cells , 2002, Journal of Mammary Gland Biology and Neoplasia.
[60] A. Saltiel,et al. Identification of CAP as a costameric protein that interacts with filamin C. , 2007, Molecular biology of the cell.
[61] L. Engel,et al. Human breast carcinoma cells in continuous culture: a review. , 1978, Cancer research.
[62] U. Sauer,et al. Morphological aspects of altered basement membrane metabolism in invasive carcinomas of the breast and the larynx. , 1998, Anticancer research.
[63] Daohai Zhang,et al. Cytokeratin 19 regulates endoplasmic reticulum stress and inhibits ERp29 expression via p38 MAPK/XBP-1 signaling in breast cancer cells. , 2009, Experimental cell research.
[64] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[65] M. Klagsbrun,et al. Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[66] E. Diamandis,et al. Proteomics Analysis of Conditioned Media from Three Breast Cancer Cell Lines , 2007, Molecular & Cellular Proteomics.
[67] D. DeFranco,et al. Mechanism of action of Hic-5/androgen receptor activator 55, a LIM domain-containing nuclear receptor coactivator. , 2006, Molecular endocrinology.
[68] D. Dabbs,et al. Erratum: Immunohistochemical Surrogate Markers of Breast Cancer Molecular Classes Predicts Response to Neoadjuvant Chemotherapy , 2011 .
[69] M. Lacroix,et al. Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update , 2004, Breast Cancer Research and Treatment.
[70] T. Ideker,et al. Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.
[71] M. Stack,et al. Processing of Laminin-5 and Its Functional Consequences: Role of Plasmin and Tissue-type Plasminogen Activator , 1998, The Journal of cell biology.
[72] Jeffrey C. Allen,et al. Tenascin-C promotes microvascular cell migration and phosphorylation of focal adhesion kinase. , 2002, Cancer research.
[73] J. Guan,et al. Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. , 2010, Cancer letters.
[74] C. Streuli,et al. Adhesion-Mediated Signaling in the Regulation of Mammary Epithelial Cell Survival , 1999, Journal of Mammary Gland Biology and Neoplasia.
[75] G. Edelman,et al. Multiple integrins mediate cell attachment to cytotactin/tenascin. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[76] J. Pringle,et al. Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms , 2009, Breast Cancer Research.
[77] S. O’Brien,et al. Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice. , 1983, Cancer research.
[78] Y. Hathout,et al. Proteomic phenotyping: metastatic and invasive breast cancer. , 2004, Cancer letters.
[79] V. Faundez,et al. Anthrax Toxin Receptor 1/Tumor Endothelium Marker 8 Mediates Cell Spreading by Coupling Extracellular Ligands to the Actin Cytoskeleton* , 2006, Journal of Biological Chemistry.
[80] Rosamonde E Banks,et al. Housekeeping proteins: A preliminary study illustrating some limitations as useful references in protein expression studies , 2005, Proteomics.
[81] A. Aszódi,et al. α11β1 Integrin-Dependent Regulation of Periodontal Ligament Function in the Erupting Mouse Incisor , 2007, Molecular and Cellular Biology.
[82] B. Gusterson,et al. Cell–matrix interactions during development and apoptosis of the mouse mammary gland in vivo , 2002, Developmental dynamics : an official publication of the American Association of Anatomists.
[83] N. Boudreau,et al. Extracellular matrix and integrin signalling: the shape of things to come. , 1999, The Biochemical journal.
[84] M. Slijper,et al. Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer , 2009, Breast Cancer Research.
[85] M. Gilcrease,et al. Integrin signaling in epithelial cells. , 2007, Cancer letters.
[86] W. Hahn,et al. Modelling the molecular circuitry of cancer , 2002, Nature Reviews Cancer.
[87] H. Hondermarck,et al. Functional Proteomics of Breast Cancer for Signal Pathway Profiling and Target Discovery , 2002, Journal of Mammary Gland Biology and Neoplasia.
[88] E. Madrigal-Bujaidar,et al. Genetic expression profiles and chromosomal alterations in sporadic breast cancer in Mexican women. , 2006, Cancer genetics and cytogenetics.
[89] J. Mier,et al. Canstatin Inhibits Akt Activation and Induces Fas-dependent Apoptosis in Endothelial Cells* , 2003, Journal of Biological Chemistry.
[90] Anita Tandle,et al. Antiangiogenic gene therapy of cancer: recent developments , 2004, Journal of Translational Medicine.
[91] Zhu Chen,et al. Palladin regulates cell and extracellular matrix interaction through maintaining normal actin cytoskeleton architecture and stabilizing Beta1‐integrin , 2007, Journal of cellular biochemistry.
[92] Wen-Lin Kuo,et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.
[93] P. Leder,et al. Human MCF10A Mammary Epithelial Cells Undergo Apoptosis following Actin Depolymerization That Is Independent of Attachment and Rescued by Bcl-2 , 2001, Molecular and Cellular Biology.
[94] A. Howell,et al. Origins of breast cancer subtypes and therapeutic implications , 2007, Nature Clinical Practice Oncology.
[95] Daniel Levy,et al. A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study , 2007, BMC Medical Genetics.
[96] M. Kuroda,et al. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome , 2002, Virchows Archiv.
[97] Manuel Théry,et al. The Universal Dynamics of Cell Spreading , 2007, Current Biology.
[98] P. Drew,et al. The proteomic analysis of cisplatin resistance in breast cancer cells. , 2007, Oncology research.
[99] R. Beroukhim,et al. Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.